Page last updated: 2024-09-05

anidulafungin and Body Weight

anidulafungin has been researched along with Body Weight in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brüggemann, RJ; Burger, DM; Knibbe, CA; Lempers, VJ; Ter Heine, R; van Dongen, EP; Wasmann, RE	1
Alvarez-Lerma, F; Barceló-Vidal, J; Campillo, N; González-Colominas, E; Grau, S; Hope, W; Horcajada, JP; Luque, S; Masclans, JR; Montero, M; Muñoz-Bermúdez, R; Sorli, L	1
Liu, P; Mould, DR	1
Coote, PJ; Harris, MR	1
Liu, P	1

Trials

1 trial(s) available for anidulafungin and Body Weight

Article	Year
Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Body Weight; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Models, Statistical; Prospective Studies; Voriconazole	2014

Article

Year

Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.

Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Body Weight; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Models, Statistical; Prospective Studies; Voriconazole

2014

Other Studies

4 other study(ies) available for anidulafungin and Body Weight

Article	Year
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:7 Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Body Weight; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Obesity, Morbid; Young Adult	2018
Population Pharmacokinetics of Anidulafungin in Critically Ill Patients. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Body Weight; Candida albicans; Candida glabrata; Candidiasis; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological	2019
Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. International journal of antimicrobial agents, 2010, Volume: 35, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Antimicrobial Cationic Peptides; Body Weight; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Humans; Kidney; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability	2010
Population pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Body Weight; Candida; Candidemia; Candidiasis, Invasive; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Echinocandins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2013